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Alzheimer’s disease (AD) is characterized by specific alterations of brain DNA methylation 
(DNAm) patterns. Age and sex, two major risk factors for AD, are also known to largely affect the 
epigenetic profiles in the brain, but their contribution to AD-associated DNAm changes has been 
poorly investigated. In this study we considered publicly available DNAm datasets of 4 brain 
regions (temporal, frontal, entorhinal cortex and cerebellum) from healthy adult subjects and AD 
patients, and performed a meta-analysis to identify sex-, age- and AD-associated epigenetic 
profiles. We showed that DNAm differences between males and females tend to be shared between 
the 4 brain regions, while aging differently affects cortical regions compared to cerebellum. We 
found that the proportion of sex-dependent probes whose methylation changes also during aging is 
higher than expected, but that differences between males and females tend to be maintained, with 
only few probes showing sex-by-age interaction. We did not find significant overlaps between AD- 
and sex-associated probes, nor disease-by-sex interaction effects. On the contrary, we found that 
AD-related epigenetic modifications are significantly enriched in probes whose DNAm changes 
with age and that there is a high concordance between the direction of changes (hyper or hypo-
methylation) in aging and AD, supporting accelerated epigenetic aging in the disease. 
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In conclusion, we demonstrated that age-associated, but not sex-associated DNAm concurs to the 
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INTRODUCTION 
 
Alzheimer’s disease (AD) is a chronic neurodegenerative disease that leads to a progressive decay 
of cognitive abilities and self-sufficiency. Neuronal loss involves multiple brain regions that are 
progressively affected by the disease. Hippocampus and entorhinal cortex exhibit the earliest 
pathological changes, preceding the onset of clinical signs and cognitive impairment by several 
years, and later the disease spreads to the other brain regions(1-4). 
Advanced age and female sex are the two major non-modifiable risk factors for AD(5-7). More than 
95% of cases of AD occur after 65 years of age (late onset AD, LOAD), and AD prevalence 
increases exponentially between 65 and 85 years (8, 9).Two-thirds of clinically diagnosed cases of 
AD are women, and the fact that women live longer than man does not fully explain this sex bias 
for AD (10, 11). 
The etiology and pathogenesis of AD are complex and likely result from the interplay between 
genetic and environmental factors during lifespan. In this scenario epigenetic modifications have 
attracted increased interest in the study of AD, as they integrate genetic background and 
environment and modulate genomic organization and gene expression. Epigenetic modifications 
regulate brain biology throughout development and lifetime, influencing neuronal plasticity, 
cognition and behavior (12), and deregulation of brain epigenetic patterns has been correlated to the 
pathogenesis of neurological and psychiatric disorders (13, 14). Several studies in post-mortem 
brain have investigated the role of DNA methylation (DNAm), the best characterized epigenetic 
modification, in AD, identifying a number of CpG sites that show robust changes in DNAm 
compared to non-demented controls (15-24).  
Interestingly, the two major non-modifiable AD risk factors mentioned above, i.e. sex and age, are 
also among the main biological variables that influence epigenetic patterns in most human tissues, 
including brain (25).  
Genome-wide DNAm differences between males and females have been found in whole blood (26) 
and have been related to the sex-biased risk of psychiatric diseases (27). A similar link has been 
reported also in brain (28)where sex-specific DNAm patterns are established early during prenatal 
development (29, 30)and are at least in part maintained in the adulthood (29, 31), contributing to the 
profound differences in brain functions between males and females (32-34) and to the different 
onset of psychiatric disorders(30).  
DNAm patterns are largely remodeled during aging (35), where a trend towards global loss of DNA 
methylation together with hypermethylation at specific loci is observed(36).Although with some 
differences between brain regions (37, 38), age-associated epigenetic changes interest also the 
brain, likely contributing to the structural and functional alterations that can resulting progressive 
cognitive decline and increased susceptibility to neurodegenerative disorders(39, 40).  
So far, only few studies have considered how sex and age interact during lifespan in shaping the 
epigenome. Data on whole blood indicate that sex-dependent DNAm is remodeled during aging 
(41), and we suggested that these changes occur at different extent in human models of successful 
and unsuccessful aging. In mouse hippocampus and human frontal cortex, Masser et al identified 
CpGs in which sex-dependent DNAm is maintained lifelong and CpG sites that are differentially 
affected by aging in relation to sex (42). Interestingly, some studies employing epigenetic clocks, 
i.e. DNAm-based predictors of age, reported accelerated aging in whole blood from males 
compared to females (43-45), and the same trend was observed also in brain (43). 
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Collectively, the available data sustain the importance of sex and aging in shaping the brain 
epigenome, but so far only one study reported sex-associated DNAm differencesthat were 
reproducible in different datasets and brain regions (28). No study has systematically analyzed 
multiple datasets and brain regions to identify DNAm patterns resulting from the interaction of sex 
and age during lifespan, and most importantly no study has evaluated whether sex- and age-
dependent DNAm can contribute to epigenetic deregulation in AD, despite the pivotal role of these 
two factors in AD etiology and pathogenesis. 
To fill this gap, in the present study we performed a meta-analysis of DNAm across sex, age and 
AD considering publicly available datasets from different brain regions. 
 
 
MATERIALS AND METHOD 
 
Datasets 
To select DNA methylation datasets based on Infinium BeadChip technology, the Gene Expression 
Omnibus (GEO) repository (46) was interrogated by the GEOmetadb Bioconductor package using 
the following search terms:“GPL13534”, “GPL21145”, to include only datasets based on the 
Illumina Infinium HumanMethylation450 and MethylationEPIC BeadChips; “sex”, “gender”, 
“female”, to include only datasets in which the information on the sex of the subjects was available; 
“age”, to include only datasets in which the information on the age of the subjects was available; 
“brain”, “cortex”, “gyrus”, “lobe”, “gray”, to select datasets in which brain samples were analysed; 
“control”, “normal”, “non-tumor”, “health”, or “Alzheiemer”, “AD”, “Braak”, to select datasets 
including healthy and AD subjects, respectively. We considered only datasets including more than 
10 healthy subjects. As to June 30th 2020, only Illumina Infinium HumanMethylation450 datasets 
were retrieved. As described in the Results section, we applied additional selection criteria 
according to the different analysis, leaving the datasetsreported in Table 1 and Table 2. 
 
Pre-processing 
As raw intensities files were not available for some datasets, all the analyses were performed on 
pre-processed methylation data downloaded from GEO. Probes mapping on sex chromosomes and 
potentially ambiguous probes (cross-reactive probes and probes including SNPs) (47)were 




To identify differentially methylated positions (DMPs), thelmFit function implemented in limma R 
package (49)was used to fit a linear model to each microarray probe, expressing DNAm as 
Mvalues. Association with age was calculated using age as a continuous value and correcting for 
sex and neuron/glia proportion. Association with sex was calculated using sex as a categorical value 
and correcting for age and neuron/glia proportion. Association with AD was calculated using AD as 
a categorical value and correcting for age, sex and neuron/glia proportion. The lmFit function was 
used also to calculated the interaction between sex and age, correcting for neuron/glia proportion, 
and between AD and sex, correcting for age and neuron/glia proportion. Effect sizes and standard 
errors were extracted from limma output.For each brain region, the results obtained in the different 
datasets were combined by inverse variance-weighted fixed-effects meta-analysis using METAL 
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted December 2, 2020. ; https://doi.org/10.1101/2020.11.25.20238360doi: medRxiv preprint 
software (50). Finally, the p-values resulting from each meta-analysis were adjusted for multiple 
comparisons using the Benjamini-Hochberg (BH) procedure. Only probes with a BH-corrected p-
value <0.01 and with concordant effect sizes between all the datasets included in each meta-analysis 
were retained as significant. 
 
Enrichment and gene ontology analysis 
Enrichment of genomic regions (Islands, N- and S-shores and shelves, open sea regions) was 
calculated using Fisher exact test, as implemented in the fisher.test function implemented in the 
stats R package. Enrichment of Gene Ontology terms was calculated using the methylgometh 
function implemented in the methylGSA R package (51), and redundant GO terms were removed by 





DNA methylation datasets of healthy and AD human brains 
We searched GEO database for datasets generated using the Illumina Infinium BeadChips on brain 
tissues from healthy and AD subjects (Materials and methods). 
For the meta-analysis of sex- and age-dependent DNA methylation in healthy subjects, we selected 
only datasets including at least 10 males and 10 females, having a minimum of 20 years and 
spanning an age range of at least 30 years. We further considered only brain regions for which at 
least 2 datasets were available. This resulted in 8 datasets covering 4 regions: Frontal cortex (FC), 
Temporal cortex (TC), Entorhinal cortex (ERC), Cerebellum (CRB) (Table 1). 
For the meta-analysis of AD-associated methylation patterns, we selected only the datasets 
including subjects over 65 years of age with at least 3 males and 3 females in the control and AD 
groups. This resulted in 8 datasets covering the same brain regions indicating above (Table 2). 
 
DNA methylation differences across sex  
To identify sex-dependent differentially methylated positions (sDMPs) we performed an epigenome 
wide association study (EWAS) in each dataset and brain region separately, correcting for age and 
estimated neuron/glia proportion (Materials and Methods). We then conducted a meta-analysis 
within each brain region. 
We identified 4860 sDMPs in FC, 1985 sDMPs in TC, 159 sDMPs in ERC and 2322 sDMPs in 
CRB (Figure 1A-D, Supplementary Figure 1and Supplementary File 1). In FC, sDMPs were 
mainlyhypermethylated in males compared to females (73% of hypermethylated probes) while the 
opposite was true for TC,ERC and CRB (38%,33% and 36% of hypermethylated probes in TC,ERC 
and CRB respectively).When analyzing the genomic context of the sDMPs, we found that CpG 
islands were enriched in sDMPs in all the 4 brain regions, and that CpG island shores showed a 
similar trend (Supplementary File 2).Also the distribution of sDMPs across chromosomes was not 
random, with a trend towards enrichment in chromosome 19 in all the 4 brain regions.The 
enrichment analysis of Gene Ontology (GO) terms did not reveal significant results except for FC, 
where the “homophilic cell adhesion via plasma membrane adhesion molecules” ontologywas 
found (SupplementaryFile 2).  
To investigate whether sex-dependent DNA methylation changes were consistent across brain 
regions, we evaluated the correlation of effect size values between FC, TC, ERC and CRB (Figure 
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2A). The 4 brain regions were positively correlated each other (Figure 2A).We next intersected the 
4sDMPs lists,identifying77 common probes mapping in 57genes (Figure 2D, Table 3 and 
Supplementary File 1). All these probes showed concordant sex-dependent DNA methylation 
profiles in the 4 brain regions and most of them (73%) were hypomethylated in males.  
On the other hand, we searched for probes having sex-related DNAm differences only in one brain 
region(region-specific sDMPs; Materials and Methods). We found 2, 4, 0 and 37region-specific 
sDMPs in FC, TC, ERC and CRB respectively (Supplementary File 1). Interestingly, 5sDMPs 
specific for CRB mapped all in the same gene, Nuclear Enriched Abundant Transcript 1 (NEAT1) 
(Figure 3). 
 
DNA methylation changes across age 
To identify age-dependent differentially methylated positions (aDMPs) we performed an EWAS in 
each dataset and brain region separately, correcting for sex and estimated neuron/glia proportion 
(Materials and Methods). We then conducted a meta-analysis within each brain region. 
We identified 24581, 10077, 404 and 1140 aDMPs in FC, TC, ERC and CRB respectively 
(Figures1E-H, Supplementary Figure 2E and Supplementary File 3). In all brain regions, most 
of theaDMPsunderwent hypermethylation with age (76%, 88%, 58% and 62% of 
hypermethylatedaDMPs in FC, RC, ERC and CRB respectively). The genomic context of aDMPs 
was not consistent across the 4 brain regions, except for a significant under-representationin “open 
sea” regions (Supplementary File 4). Similarly, aDMPs were differently scattered across 
chromosomes in FC, TC, ERC and CRB. GO enrichment analysis revealed several pathways 
involved in morphogenesis anddevelopmentalprocesses, with “pattern specification process” and 
“regionalization” common to FC, TC and ERC (Supplementary File 4). 
The analysis of correlation between the effect sizes revealed that age-associated changes were more 
similar between FC and TC compared to the other regions (Figure 2B).The intersection of the 
aDMPs from the 4 brain regions highlighted 28 common probes, all concordantly undergoing 
hypermethylation with age and mapping in 25 genes (Figure 2E and Table 4). The opposite 
analysis, i.e. the identification of region-specific aDMPs (Materials and Methods), identified only 1 
probe specific for FC (cg01725130), that maps in the body of Ras And Rab Interactor 3 (RIN3) 
gene (Supplementary File 2). 
 
Relation between age and sex in brain DNA methylation  
We then aimed at studying how sex-specific brain DNAm is modulated during aging. 
First of all, we intersected sDMPs and aDMPslists. In FC, we found 675 probes that change with 
sex and with age (s&aDMPs), corresponding to about 13% of all sDMPs identified. In TC 
s&aDMPs were 171, corresponding to 8.5%of sDMPs. In ERC we found only 2s&aDMPs, while in 
CRBs&aDMPswere 19, corresponding to 4% of sDMPs(Figure 4 and Supplementary Files 1 and 
3). In all the four regions, the proportion of sDMPs changing with age (i.e., the proportion of 
s&aDMPs) was higher than expected (Fisher’s Exact Test p-value <0.05; odds ratio of 2.6, 3.8,13.0 
and3.0 in FC, TC, ERC and CRB respectively). InFC, TC and CRB, most of the s&aDMPs were 
probes having higher DNAm levels in males respect to females and undergoing hypermethylation 
during aging. GO analysis revealed only 1 ontology enriched in FC (“homophilic cell adhesion via 
plasma membrane adhesion molecules”). 
The previous analysis identifies CpG probes whose DNAm changes according to both sex and age, 
but is not informative about possible differences in aging trajectories between males and females. 
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To fulfill this point, we performed an age-by-sex interaction analysis in each dataset(Materials and 
Methods) and meta-analyzed the results for the 4 brain regions. Only 4, 4, 2 and 2 probes showed a 
significant age-by-sex interaction in FC, TC, ERC and CRB respectively (Supplementary File 5). 
 
Brain DNA methylation changes across AD 
Finally, we focused on brain DNAm datasets including late onset AD patients (LOAD) and age-
matched non-demented controls.  
To identify differentially methylated positions associated with LOAD (LOAD-DMPs) we 
performed an EWAS in each dataset and brain region separately, correcting for age, sex and 
estimated neuron/glia proportion (materials and methods). We then conducted a meta-analysis 
within each brain region. 
We identified14 LOAD-DMPs in FC, 5405 in TC, 47 in ERC and only 1 in CRB (Figures 1I-N), 
Supplementary Figure 3 and Supplementary File 6). In all brain regions most of LOAD-DMPs 
were hypermethylated in AD compared to controls (93%,80%, 76% and 100% in FC, TC, ERC and 
CRB respectively).While in TC LOAD-DMPs were significantly under-represented in CpG islands 
and enriched in the other genomic contexts, a significant enrichment in CpG islands was found for 
LOAD-DMPs identified in FC (Supplementary File 7). GO analysis returned significant results 
only in TC, where pathways related to synapse organization and function were found 
(Supplementary File 7). 
Correlation analysis of effect size between 4 brain regions highlighted a distinctive pattern in CRB 
respect to FC, TC and ERC, while the correlation was higher between TC and ERC (Figure 2C). 
Accordingly the intersection between LOAD-DMPs in the 4 brain regions did not return common 
probes, while 29 probes (mapping in 23 genes)and 8 probes (mapping in 6 genes) were identified by 
intersecting TC and ERCor FC and TC, respectively (Figure 2Fand Table 5). The 
probecg12163800, mapping in Rhomboid 5 Homolog 2 (RHBDF2) gene, was significantly 
hypermethylated in FC, TC and ERC from AD patients.  
 
Relation between sex- and age-associatedDNAm changes and AD epigenetic remodeling 
Finally, we explored whether AD-associated DNAm changes were related to sex- and age-specific 
brain DNAm patterns occurring in physiological conditions, identified in the above described 
analyses. 
In each brain region, we intersected the LOAD-DMPs and sDMPs in orderto identify 
LOAD&sDMPs, i.e. probes that have basal differential DNAm between the two sexes and are also 
affected by AD.The intersection did not result in any probe for all the regions except that for TC, 
where we found 23LOAD&sDMPs, mapping in 16 genes and corresponding to only0.4% of 
LOAD-DMPs in TC (Fisher’s Exact Test p-value >0.05)(Figure 4andSupplementary Files 1 and 
6).Moreover, AD-by-sex interaction analysis yielded no significant probes in any regions. 
Similarly, we explored whether LOAD-DMPs occur in probes whose DNAm changes during 
physiological aging process (LOAD&aDMPs). The intersection between LOAD-DMPs and aDMPs 
highlighted 7, 456, 4 and 0 probes in FC, TC, ERC and CRB respectively(Figure 4).The proportion 
of LOAD&aDMPs was higher than expected by chance in FC, TC and ERC (Fisher’s Exact Test p-
value <0.05; odds ratio of 15.9, 3.8 and 95in FC, TC and ERC respectively). We found that the 87% 
of LOAD&aDMPs in TC are concordant for the effect size sign between aDMPs and LOAD-
DMPs, while this percentage reached 100% in FC e ERC. Notably, the 4LOAD&aDMPsfound in 
ERC (cg11823178, cg03169557, cg25018458 and cg22090150, mapping in SPG7 Matrix AAA 
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Peptidase Subunit, Paraplegin [SPG7], Ankyrin1 [ANK1/MIR486], Ankyrin Repeat And FYVE 
Domain Containing 1 [ANKFY1] and ABR Activator Of RhoGEF And GTPase [ABR] 
respectively)were also found in TC.Also the intersection between LOAD&aDMPs in TC and FC 
resulted in 4 common probes: cg22962123, mapping in PDZ And LIM Domain 2 (PDLIM2) gene; 
cg07061298, not mapping in any gene; cg01463828 and cg04874795, both mapping in Homeobox 
A3 (HOXA3) gene. Figure 5 reports DNAm values of cg11823178 (ANK1) and cg22962123 
(PDLIM2) in TC from GSE134379 dataset as an example of CpG sites displaying a positive 
association of DNAm with age and hypermethylated in AD. 
Finally, it is worth to note that TC is the exclusive brain region in which we found probes at the 
intersection between aDMPs, sDMPs and LOAD-DMPs (LOAD&a&sDMPs)(Figure 4B).The 5 
probes (cg20225999, cg03951603, cg08820801, cg22263793, cg10828284) which mapped inF-Box 
Protein 17 (FBXO17), Mov10 Like RISC Complex RNA Helicase 1(MOV10L1)genes were all 
hypermethylated in males and with aging; three of them (cg20225999, cg08820801, cg10828284) 




Sex and age are among the major risk factors for AD. In this paper we performed a meta-analysis of 
DNAm changes that are associated to sex and aging in 4 brain regions (FC, TC, ERC, CRB) and we 
evaluated whether they contribute to the epigenetic alterations that have been widely described in 
AD. Our main findings are summarized in the following paragraphs. 
 
Sex-dependent DNAm differences tend to be shared between brain regions, with few 
exceptions 
To date some studies have reported DNAm sex differences in human brain, mainly focusing on 
frontal cortex (29-31, 42) with few exceptions (28). Our meta-analysis confirms the presence of 
autosomic probes with differential methylation between males and females in all the brain regions. 
These probes preferentially map in CpG islands and shores suggesting their involvement in the 
regulation of sex-specific gene expression in brain(31).  
Sex specific DNAm tend to be reproducible across the brain regions and 77 CpGs resulted from the 
cross-region intersection. Among them there are sDMPs mapping in genes that have been already 
associated to sex differences in brain physiology and pathology, likePar-3 Family Cell Polarity 
Regulator Beta (PARD3B)(53), DEAF1 Transcription Factor (DEAF1)(54) and Iodothyronine 
Deiodinase 3 (DIO3)(55) genes. Most of these 77 probes were previously reported as differentially 
methylated between males and females also in previous meta-analysis on blood(56, 57). 
In addition, we found few examples of sDMPs specific for a brain region. The most notable 
example is in cerebellum and maps in NEAT1.  NEAT1 is a ubiquitously expressed long non-
coding RNA (lncRNA) involved in a plethora of neurospecific processes such as brain development 
and aging (58-60). Recent transcriptomic studies on human CNS revealed altered NEAT1 levels in 
AD (61),PD (62) and in schizophrenia (63). 
 
DNAm tends to be differently remodeled during aging according to the brain region 
Several studies have analyzed age-associated changes in DNAm in brain, both comparing fetal 
versus adult brains and analyzing methylation profiles across adulthood(13, 16, 38, 64-67). Our 
meta-analysis showes that during aging there is an increase of methylation at specific loci, 
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accordingly to previously published data on blood (56, 68)and brain (38). As previously reported by 
Hernandez et al (38), also our results support the involvement of brain aDMPs in GO related to 
developmental processes and morphogenesis. Furthermore, our meta-analysis confirms and extends 
the observation that the epigenome is differently remodeled during aging across brain 
regions(38).In particular we observed thatage-associated DNAm patterns are similar in TC and FC, 
while they are distinct in ERC and CRB. CRB was previously described to undergo to a peculiar 
epigenetic aging, which was decelerated according to Horvath’s epigenetic clock(37). 
The large fraction (93%) of the 28 aDMPs emerged from our cross region analysis was found also 
in aging studies on blood (56). Among them there are probes mapping in Four And A Half LIM 
Domains 2 (FHL2) and ELOVL Fatty Acid Elongase 2 (ELOVL2) genes, previously reported as 
age-associated in large number of studies on several tissues (69, 70)including sorted neuron and glia 
cells(16). According to what discussed above and to previous results (69, 71) the effect size of 
ELOVL2 probe cg16867657 was lower in CRB respect the other regions, but still significant in our 
meta-analysis. Elovl2 is an enzyme involved in the elongation of fatty acids and its functional role 
in aging has been recently suggested (72). 
 
Sites with sex-dependent DNAm are similarly modulated during aging in males and females 
Previous studies in mice and humans suggested that, while sex-differences in DNAm at certain CpG 
sites are maintained during life, other CpG sites show sexually divergent aging patterns, i.e they 
have a different response to aging in males and females(42). Our meta-analysis supports the fact 
that sDMPs have a high propensity to be modulated during aging, as the intersection of sDMPs and 
aDMPs is higher than expected in all the 4 brain regions. However, we found only few probes with 
significant sex-by-age interaction, indicating similar rather than diverging changes in DNAm in 
males and females aging. The discrepancy between our results and previous findingscan be due to 
different reasons: for example, while Masser et al. considered only one dataset including frontal 
cortex data, here we meta-analysed several datasets using selective criteria of concordance between 
all datasets from the same brain region; furthermore, we applied a filtering step that removed 
potentially ambiguous probes, thus reducing the potential overlap with Masser’s results. Our results 
are more similar to what reported by two independent studies in blood (41, 56),which showed that 
only a small fraction of CpGs have significant sex-by-age interaction. Further studies on larger 
cohorts are needed to better describe sex-dependent DNAm patterns during brain aging. 
 
 
Epigenetic changes in AD are enriched in sites that show age- but not sex-dependent DNAm 
A recent meta-analysis on EWAS studies identified 220 CpGs associated with AD neuropathology, 
shared by brain cortical cortex regions but not by CRB(73). The paper by Smith et al. included 
several datasets that we used also in our meta-analysis, with the exception of GSE125895 and 
GSE109627, while we did not have access to the ROS/MAP and RBD DNAm data. Furthermore, 
while Smith et al. considered the association with Braak stage, here we used the disease as a binary 
trait (affected/unaffected). Despite these differences, our results largely overlap with those 
previously reported. In particular, we did not find AD-related probes common to all the 4 brain 
regions that we investigated, with CRB DNAm clearly less affected by the pathology. On the 
contrary, a subset of sites was shared between FC, TC and ERC, and about 50% of these probes 
overlap with published data. These probes map within genes whose epigenetic deregulation has 
been largely documented in AD, including ANK1, RHBDF2 and HOXA3. On the contrary, we did 
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not find any overlapwhen comparing our results on AD brain with CpG sites identified in AD 
patients’ blood (74), confirming that the pathology differently affects the two tissues as recently 
reported(75). 
We did not find a significant overlap between LOAD-DMPs and sDMPs, nor we found significant 
interaction effects between sex and AD. Overall these results suggest that AD does not 
predominantly insist on sites with sex-specific DNAm, and that the epigenetic differences between 
the two sexes do not contribute to the different prevalence of the disease in males and females. 
Conversely, our data show that in FC, TC and ERC, AD-related epigenetic modifications are 
significantly enriched in probes whose DNAm changes with age. Strikingly, we found a high 
concordance between the direction of DNAm changes (hyper or hypo-methylation)in 
LOAD&aDMPs, indicating that a subset of age-associated DNAm changes are exaggerated in AD. 
In TC, LOAD&aDMPs included probes mapping inANK1, and it is worth to note that the down-
regulation of Ank2 (ANK1 human orthologue gene) in Drosophila has been associated to memory 
loss, neuronal dysfunction and shortened lifespan in a recent report(76). 
Overall, these results support a geroscience view(77-80)according to which AD can be considered a 
deviation of the physiological aging trajectories towards accelerated aging. Epigenetic age 
acceleration was previously reported in AD neurons, were a pronounced loss of CpH methylation 
was found at enhancers, similar to what observed in aging, and in bulk prefrontal cortex, where 
epigenetic age calculated by Horvath’s clock was positively associated with neuritic plaques and 
amyloid load (81). It will be interesting to know whether similar results will be obtained using the 
recently published epigenetic clock optimized for brain tissues(82). 
 
Strengths, limitations and conclusion 
To the best of our knowledge, this is the first report in which sex-, age- and AD-related DNAm 
changes are systematically assessed using the same analytical approach. Furthermore, we used 
stringent selection criteria that enabled to select only probes with concordant DNAm changes in the 
different datasets. On the other side, our study has some limitations. The datasets that we meta-
analysed largely vary in size and age range of the assessed subjects, an aspect important for the 
identification of aDMPs. Moreover, in all the datasets it was not possible to distinguish 5-
methylcytosine from 5-hydroxymethylcytosine, an epigenetic modification that contributes to both 
brain function and neurodegeneration(17, 73, 83, 84). Finally, the datasets that we meta-analysed 
were based on bulk brain tissues. Although all the analyses were corrected for neuron/glia 
proportions predicted from DNAm data, we cannot exclude that the observed sex-, age- and LOAD-
associated DNAm changes are at least in part driven by changes in brain cells composition that 
occur in physiological and pathological conditions. For example, Gasparoni et al reported that 
ANK1 deregulation in AD is specific for glial cells (16), a finding further supported by gene 
expression studies (85), and that the epigenetic profiles of neurons and glia are differently 
modulated during aging. Notwithstanding, our results suggest that (cell-specific) age-associated 
remodelling of DNAm is not just a confounding factor for the epigenetic deregulation observed in 
AD, but on the contrary it is the predisposing milieu in which AD pathogenetic mechanisms are 
established. 
In conclusion, we demonstrated that age-associated, but not sex-associated DNAm patterns concurs 
to the epigenetic deregulation observed in AD, providing new insight on how advanced age enables 
neurodegeneration. 
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Abbreviations 
DNAm: DNA methylation 
AD: Alzheimer’s Disease 
DMPs:differentially methylated positions 
LOAD: Late Onset Alzheimer’s Disease 
EWAS: Epigenome-Wide Association Study 
GO: Gene Ontology 
sDMPs: sex-associated differentially methylated positions 
aDMPs: age-associated differentially methylated positions 
s&aDMPs: sex- and age-associated differentially methylated positions 
LOAD&aDMPs: Late Onset Alzheimer’s Disease-specific age-associated differentially methylated 
positions 
LOAD&sDMPs: Late Onset Alzheimer’s Disease-specific sex-associated variably methylated 
positions 
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Figure 1. Sex-, age- and AD- associated epigenetic remodeling in the four brain regions. 
Volcano plots of -log10(P-value) against effect sizes, resulting from the meta-analysis of: sex-
associated DMPs in FC (A), TC (B), ERC (C) and CRB (D); age-associated DMPs in FC (E), TC 
(F), ERC (G) and CRB (H); LOAD-associated DMPs in FC (I), TC (L), ERC (M) and CRB (N). 
Significant probes (BH-corrected p-value < 0.05) are colored in black. 
Figure 2. Cross-region analysis of sex-, age- and AD-associated probes. (A-C) Correlation 
matrix plots show the magnitude of correlation between probes effect sizes in the 4 brain regions, 
considering the result of the meta-analysis onsex- (A), age- (B) and AD- (C) associated probes. 
Positive and negative correlation values are indicatedin blue and red respectively. (D-F) Venn 
diagrams display the number of significant DMPs shared between the 4 brain regions, considering 
sDMPs (D), aDMPs (E) and LOAD-DMPs (F). The genes in which map the most shared probes are 
reported below each diagram.  
Figure 3. CRB-specific sex-associated DNAm of NEAT1 gene. Forest plot of the three CRB-
specific sDMPs mapping inNEAT1gene: (A) cg16884222, (B) cg09411730, (C) cg07985890. For 
each probe, effect sizes from the datasets used for our meta-analysis are reported, dividing them 
according to the 4 brain regions (CRB, yellow; FC, magenta; TC, cyan; ERC, gray) 
Figure 4. Intersections of sex-, age- and AD-associated probes in each of the four brain 
regions. Venn diagrams depict the intersection between sDMPs, aDMPs and LOAD-DMPs in FC 
(A), TC (B), ERC (C) and CRB (D).  
Figure 5. Scatter plots of ANK1 and PDLIM2 DNAm according to age and disease. Scatter 
plots of methylation values of cg11823178 within ANK1(A) and of cg22962123 within PDLIM2 
(B) in TC from GSE134379 dataset). Healthy subjects are colored in gray while AD patients are in 




Supplementary Figure 1. Manhattan plots of sDMPs in the four brain regions. The figure 
displays the Manhattan plots resulting from the meta-analysis of sex-associated probes in FC (A), 
TC (B), ERC (C) and CRB (D). Significant sDMPs are marked with dark color. Scale change 
across 50 is indicated by an axis break. 
Supplementary Figure 2. Manhattan plots of aDMPs in the four brain regions. The figure 
displays the Manhattan plots resulting from the meta-analysis of age-associated probes in FC (A), 
TC (B), ERC (C) and CRB (D). Significant aDMPs are marked with dark color. Scale change 
across 50 is indicated by an axis break. 
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Supplementary Figure 3. Manhattan plots of LOAD-DMPs in the four brain regions. The 
figure displays the Manhattan plots resulting from the meta-analysis of AD-associated probes in FC 
(A), TC (B), ERC (C) and CRB (D). Significant LOAD-DMPs are marked with dark color.  
 
Supplementary file 1. Significant sDMPs in the four brain regions. The tables report the lists of 
sDMPs for each brain regions (FC, TC, ERC and CRB). Probes resulting from the analysis of cross-
region and region-specific sDMPs are indicated by a cross, together with the probes that are in 
common with aDMPs or LOAD-DMPs found in the same region.  
 
Supplementary file 2.Enrichment analysis of sDMPs. The tables report: 1) the results of Fisher’s 
test on genomic distribution of sDMPs for each brain region, considering genomic context and 
chromosomal location. Significant results (p-value<0.05) are colored in green or red if depleted or 
enriched respectively. 2) the results of GO pathway enrichment analysis, after REVIGO filtering. 
Only the significant results (adjusted p-value <0.01) for each brain region are reported. 
Supplementary file 3. Significant aDMPs in the four brain regions. The tables report the lists of 
aDMPs for each brain regions (FC, TC, ERC and CRB). Probes resulting from the analysis of cross-
region and region-specific sDMPs are indicated by a cross, together with the probes that are in 
common with sDMPs or LOAD-DMPs found in the same region. 
 
Supplementary file 4. Enrichment analysis of aDMPs. The tables report: 1) the results of 
Fisher’s test on genomic distribution of aDMPs for each brain region, considering genomic context 
and chromosomal location. Significant results (p-value<0.05) are colored in green or red if depleted 
or enriched respectively. 2) the results of GO pathway enrichment analysis, after REVIGO filtering. 
Only the significant results (adjusted p-value <0.01) for each brain region are reported. 
 
Supplementary file 5. Probes with significant sex-by-age interaction in the four brain regions. 
The tables report the lists of probes with significant sex-by-age interaction in each brain region (FC, 
TC, ERC and CRB). 
 
Supplementary file 6. Significant LOAD-DMPs in the four brain regions. The tables report the 
lists of LOAD-DMPs for each brain regions (FC, TC, ERC and CRB). Probes resulting from the 
analysis of cross-region and region-specific LOAD-DMPs are indicated by a cross, together with 
the probes that are in common with sDMPs or aDMPs found in the same region. 
 
Supplementary file 7.Enrichment analysis of LOAD-DMPs. The tables report: 1) the results of 
Fisher’s test on genomic distribution of LOAD-DMPs for each brain region, considering genomic 
context and chromosomal location. Significant results (p-value<0.05) are colored in green or red if 
depleted or enriched respectively. 2) the results of GO pathway enrichment analysis, after REVIGO 
filtering. Only the significant results (adjusted p-value <0.01) for each brain region are reported. 
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Table 1. Characteristics of the Infinium450kdatasets including healthy subjects selected in the 
present study for the age and sex analyses. 
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Table 2. Characteristics of the Infinium450kdatasets investigated in the present study including AD 
patients and non-demented control subjects. 
 
 





(F/M) Age range 
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Ctrl: non-demented control subjects; AD: Alzheimer’s disease patients 
  
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted December 2, 2020. ; https://doi.org/10.1101/2020.11.25.20238360doi: medRxiv preprint 
 
 
Table 3. List of sDMPs resulted from cross-region analysis. 
 
Probe Chr MAPINFO Relation 
Gene Effect size 
direction 
Yusipov et al. 
 
cg00097357 12 33591336 N_Shore SYT10 - X 
cg00655923 7 64895418   + X 
cg00760935 4 1.55E+08 Island DCHS2 - X 
cg01063965 11 695461 Island TMEM80, DEAF1 -  
cg01181499 2 74739419 N_Shore  - X 
cg01906879 3 81811016 S_Shore GBE1 - X 
cg02093808 4 77342011 Island  - X 
cg02297043 1 75590912 Island  - X 
cg02530860 8 1.44E+08 Island  + X 
cg03168896 3 44036098 N_Shore  - X 
cg03405128 4 77341841 N_Shore  - X 
cg03687700 2 24271844 N_Shore FKBP1B - X 
cg03894796 8 1.44E+08 Island  + X 
cg04946709 16 59789030 Island LOC644649 + X 
cg05020125 8 37605552  LOC728024, ERLIN2 - X 
cg05056638 8 24800824 S_Shore  - X 
cg05100634 18 45457604 Island SMAD2 -  
cg05468028 21 30391383 Island RWDD2B - X 
cg05849319 11 65172370 Island FRMD8 + X 
cg06666376 19 3480596 N_Shore C19orf77 + X 
cg06710937 13 23489940 Island  - X 
cg07462804 4 81105375 Island PRDM8 - X 
cg07645761 16 2892518 N_Shore TMPRSS8 + X 
cg07953307 16 29000920  LAT + X 
cg08541880 3 1.38E+08 Island DZIP1L - X 
cg09045105 1 1.5E+08 Island BOLA1 - X 
cg09725915 2 70369583 Island  - X 
cg09971754 16 89557657 Island ANKRD11 + X 
cg10546176 5 34929404 Island DNAJC21 - X 
cg10749792 7 56119218 Island PSPH, CCT6A - X 
cg10776186 13 25875020 Island NUPL1 - X 
cg11065518 2 2.08E+08 S_Shore MDH1B, FASTKD2 - X 
cg11174255 4 1513259 N_Shore  + X 
cg11240062 8 1.44E+08 Island  + X 
cg11565911 12 72233249 N_Shore TBC1D15 - X 
cg11841231 2 2.06E+08  PARD3B + X 
cg12356266 8 99984350 N_Shore  - X 
cg12611527 2 1.57E+08 Island  - X 
cg12611723 9 1.4E+08 Island NPDC1 - X 
cg13230424 17 45930033 S_Shore SP6 - X 
cg13346869 8 37605517  LOC728024, ERLIN2 - X 
cg14030268 10 1.19E+08 Island PDZD8 - X 
cg14373579 9 1.33E+08 Island LOC100272217, FUBP3 - X 
cg15148078 19 3480561 N_Shore C19orf77 + X 
cg15817705 1 2.09E+08 S_Shore  + X 
cg16021159 1 57142074  PRKAA2 + X 
cg16374663 15 41805031 Island LTK - X 
cg17561891 7 86849173 Island C7orf23 - X 
cg17743279 7 92463268 Island CDK6 - X 
cg17887478 17 7486551 Island MPDU1 - X 
cg18001427 21 30391784 S_Shore RWDD2B - X 
cg18721420 19 15121913 Island CCDC105 - X 
cg19292062 20 524344 Island CSNK2A1 - X 
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cg19311244 4 77341912 N_Shore  - X 
cg19864758 20 17206720 Island PCSK2 - X 
cg20050113 2 1.03E+08 S_Shore SLC9A2 - X 
cg20432211 4 77342104 Island  - X 
cg22105158 19 3480672 N_Shore C19orf77 + X 
cg22266749 4 1.1E+08 Island COL25A1 + X 
cg22345911 17 80231263 Island CSNK1D - X 
cg22794378 14 89029563 Island ZC3H14 -  
cg22799420 14 1.02E+08 Island DIO3 - X 
cg22889142 19 58862398 Island NCRNA00181, A1BG - X 
cg23001456 17 2615074 Island KIAA0664 - X 
cg23719534 15 1.01E+08 Island  -  
cg23880736 4 582172 Island  + X 
cg24016844 1 1.12E+08 Island C1orf103 + X 
cg24126849 4 581937 N_Shore  + X 
cg24158363 17 73401717 Island GRB2 - X 
cg24717799 15 83680832 S_Shore C15orf40 - X 
cg24990494 13 32520050  EEF1DP3 +  
cg25584814 19 345306 Island MIER2 - X 
cg25726513 4 1340596 Island KIAA1530 - X 
cg26172013 20 32031452 Island SNTA1 - X 
cg26516287 7 12629275  SCIN - X 
cg26612727 17 38024636 Island ZPBP2 - X 
cg27645294 17 21795257   - X 
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Table 4. List of aDMPs resulting from cross-region  
Probe Chr MAPINFO Relation 
Gene Effect size 
direction 
Yusipov et al. 
 
 
cg00292135 7 156433068 Island C7orf13, RNF32 + X 
cg04090392 15 83952774 Island BNC1 + X 
cg06639320 2 106015739 Island FHL2 + X 
cg06942814 7 27170819 S_Shore HOXA4 + X 
cg07303143 3 44803452 Island KIAA1143;KIF15 + X 
cg07525420 10 131761181 Island EBF3 + X 
cg07922606 6 26225389 Island HIST1H3E +  
cg11614451 3 160167729 Island TRIM59 +  
cg12373771 22 17601381 Island CECR6 + X 
cg13327545 10 22623548 Island  + X 
cg14020846 14 103674272 Island  + X 
cg14556683 19 15342982 Island EPHX3 + X 
cg15243034 11 77907656 Island USP35 + X 
cg15341124 14 102027734 Island DIO3, MIR1247 + X 
cg15611336 15 75248496 Island RPP25 + X 
cg16295725 4 10459219 Island ZNF518B + X 
cg16867657 6 11044877 Island ELOVL2 + X 
cg16969368 17 57642752 Island DHX40 + X 
cg18008766 2 38978896 S_Shore SFRS7 + X 
cg18240400 10 46168597 Island ANUBL1 + X 
cg18473521 12 54448265 S_Shore HOXC4 + X 
cg19399220 19 10527588 Island  + X 
cg20591472 1 110008990 Island SYPL2 + X 
cg23995914 4 10459228 Island ZNF518B + X 
cg24079702 2 106015771 Island FHL2 + X 
cg24567591 16 3931229 Island CREBBP + X 
cg24903144 10 102509268 Island PAX2 + X 
cg26092675 6 26225258 N_Shore HIST1H3E + X 
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Table 5. List of LOAD-DMPs resulting from cross-region analysis. 
 
Intersection Probe Chr MAPINFO Relation 
Gene Effect size 
direction 
Smith et al. 








cg00851830 14 100201016 N_Shelf  +  
cg03169557 16 89598950  SPG7 + X 
cg03183618 2 134964228   +  
cg04658038 17 64800166  PRKCA +  
cg05066959 8 41519308  ANK1, MIR486 + X 
cg05397697 14 90042217  PRO1768, FOXN3 +  
cg05417607 17 1373605 N_Shore MYO1C + X 
cg05810363 17 74475270 Island RHBDF2 + X 
cg06653632 12 129281444 S_Shore SLC15A4 +  
cg06753513 17 3977385  ZZEF1 +  
cg07012687 17 80195180 Island SLC16A3 +  
cg07571519 10 73472315  C10orf105 +  
cg09123026 17 74480528  RHBDF2 +  
cg11823178 8 41519399  ANK1, MIR486 + X 
cg12163800 17 74475355 Island RHBDF2 + X 
cg12309456 17 74475402 Island RHBDF2 + X 
cg13851211 16 50321678  ADCY7 +  
cg14025831 20 3873404 S_Shelf PANK2 +  
cg14761246 3 182968758 N_Shelf MCF2L2 +  
cg14798745 4 184315677 N_Shelf  +  
cg18102633 19 17487776 N_Shore PLVAP +  
cg18456331 10 77188318 N_Shelf  +  
cg18923906 10 82225771  TSPAN14 +  
cg20148994 7 130125585 N_Shore MEST +  
cg21221455 15 63342288 S_Shore TPM1 +  
cg22090150 17 4098227  ANKFY1 + X 
cg22656126 17 1637206 Island WDR81 +  
cg25018458 17 980014 N_Shore ABR + X 


















cg01463828 8 22446721  PDLIM2 + X 
cg02317313 12 1,22E+08 Island LOC338799 + X 
cg04874795 16 86477638   - X 
cg07061298 7 27153847 N_Shore HOXA3; + X 
cg12163800 17 74475355 Island RHBDF2 + X 
cg22962123 7 27153605 Island HOXA3 + X 
cg26022064 7 98739782 N_Shore SMURF1 + X 









cg12163800 17 74475355 Island RHBDF2 + X 
cg13076843 17 74475294 Island RHBDF2 + X 
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